BindingDB logo
myBDB logout

PubMed code 15139763

Compile data set for download or QSAR
Found 41 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
BDKRB2


(HUMAN)
BDBM50146893
PNG
(4-{(E)-2-[({[2,4-Dichloro-3-(4-ethoxy-2-methyl-qui...)
Show SMILES CCOc1cc(C)nc2c(OCc3c(Cl)ccc(N(C)C(=O)CNC(=O)\C=C\c4ccc(cc4)C(=O)NC)c3Cl)cccc12
Show InChI InChI=1S/C33H32Cl2N4O5/c1-5-43-28-17-20(2)38-32-23(28)7-6-8-27(32)44-19-24-25(34)14-15-26(31(24)35)39(4)30(41)18-37-29(40)16-11-21-9-12-22(13-10-21)33(42)36-3/h6-17H,5,18-19H2,1-4H3,(H,36,42)(H,37,40)/b16-11+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 0.190n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Concentration required to inhibit specific binding of [3H]-BK(0.06 nM) to the bradykinin receptor B2


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146905
PNG
(4-{(E)-2-[({[2,4-Dichloro-3-(4-methoxy-2-methyl-qu...)
Show SMILES CNC(=O)c1ccc(\C=C\C(=O)NCC(=O)N(C)c2ccc(Cl)c(COc3cccc4c(OC)cc(C)nc34)c2Cl)cc1
Show InChI InChI=1S/C32H30Cl2N4O5/c1-19-16-27(42-4)22-6-5-7-26(31(22)37-19)43-18-23-24(33)13-14-25(30(23)34)38(3)29(40)17-36-28(39)15-10-20-8-11-21(12-9-20)32(41)35-2/h5-16H,17-18H2,1-4H3,(H,35,41)(H,36,39)/b15-10+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 0.230n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Concentration required to inhibit specific binding of [3H]-BK(0.06 nM) to the bradykinin receptor B2


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146907
PNG
(5-((E)-2-{[({2,4-Dichloro-3-[2-methyl-4-(pyridin-2...)
Show SMILES CN(C(=O)CNC(=O)\C=C\c1ccc(nc1)C(=O)N\C=C\c1ccncc1)c1ccc(Cl)c(COc2cccc3c(OCc4ccccn4)cc(C)nc23)c1Cl
Show InChI InChI=1S/C42H35Cl2N7O5/c1-27-22-37(55-25-30-6-3-4-18-46-30)31-7-5-8-36(41(31)50-27)56-26-32-33(43)11-13-35(40(32)44)51(2)39(53)24-49-38(52)14-10-29-9-12-34(48-23-29)42(54)47-21-17-28-15-19-45-20-16-28/h3-23H,24-26H2,1-2H3,(H,47,54)(H,49,52)/b14-10+,21-17+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 0.360n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Inhibition of [3H]BK (1.0 nM) binding to the human bradykinin receptor B2, expressed in CHO cells


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146895
PNG
(4-((E)-2-{[({2,4-Dichloro-3-[2-methyl-4-(pyridin-2...)
Show SMILES CN(C(=O)CNC(=O)\C=C\c1ccc(cc1)C(=O)Nc1ccncc1)c1ccc(Cl)c(COc2cccc3c(OCc4ccccn4)cc(C)nc23)c1Cl
Show InChI InChI=1S/C41H34Cl2N6O5/c1-26-22-36(53-24-30-6-3-4-19-45-30)31-7-5-8-35(40(31)47-26)54-25-32-33(42)14-15-34(39(32)43)49(2)38(51)23-46-37(50)16-11-27-9-12-28(13-10-27)41(52)48-29-17-20-44-21-18-29/h3-22H,23-25H2,1-2H3,(H,46,50)(H,44,48,52)/b16-11+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 0.400n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Inhibition of [3H]BK (1.0 nM) binding to the human bradykinin receptor B2, expressed in CHO cells


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146899
PNG
(4-((E)-2-{[({2,4-Dichloro-3-[2-methyl-4-(pyridin-2...)
Show SMILES CNC(=O)c1ccc(\C=C\C(=O)NCC(=O)N(C)c2ccc(Cl)c(COc3cccc4c(OCc5ccccn5)cc(C)nc34)c2Cl)cc1
Show InChI InChI=1S/C37H33Cl2N5O5/c1-23-19-32(48-21-26-7-4-5-18-41-26)27-8-6-9-31(36(27)43-23)49-22-28-29(38)15-16-30(35(28)39)44(3)34(46)20-42-33(45)17-12-24-10-13-25(14-11-24)37(47)40-2/h4-19H,20-22H2,1-3H3,(H,40,47)(H,42,45)/b17-12+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 0.410n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Inhibition of [3H]BK (1.0 nM) binding to the human bradykinin receptor B2, expressed in CHO cells


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50067281
PNG
(4-{(E)-2-[({[2,4-Dichloro-3-(2-methyl-quinolin-8-y...)
Show SMILES CNC(=O)c1ccc(\C=C\C(=O)NCC(=O)N(C)c2ccc(Cl)c(COc3cccc4ccc(C)nc34)c2Cl)cc1
Show InChI InChI=1S/C31H28Cl2N4O4/c1-19-7-11-21-5-4-6-26(30(21)36-19)41-18-23-24(32)14-15-25(29(23)33)37(3)28(39)17-35-27(38)16-10-20-8-12-22(13-9-20)31(40)34-2/h4-16H,17-18H2,1-3H3,(H,34,40)(H,35,38)/b16-10+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 0.510n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Concentration required to inhibit specific binding of [3H]-BK(0.06 nM) to the bradykinin receptor B2 in guinea pig ileum membrane


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146903
PNG
(CHEMBL98460 | N-[4-((E)-2-{[({2,4-Dichloro-3-[2-me...)
Show SMILES CN(C(=O)CNC(=O)\C=C\c1ccc(NC(=O)c2ccncc2)cc1)c1ccc(Cl)c(COc2cccc3c(OCc4ccccn4)cc(C)nc23)c1Cl
Show InChI InChI=1S/C41H34Cl2N6O5/c1-26-22-36(53-24-30-6-3-4-19-45-30)31-7-5-8-35(40(31)47-26)54-25-32-33(42)14-15-34(39(32)43)49(2)38(51)23-46-37(50)16-11-27-9-12-29(13-10-27)48-41(52)28-17-20-44-21-18-28/h3-22H,23-25H2,1-2H3,(H,46,50)(H,48,52)/b16-11+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 0.560n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Inhibition of [3H]BK (1.0 nM) binding to the human bradykinin receptor B2, expressed in CHO cells


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50067289
PNG
((E)-3-(6-Acetylamino-pyridin-3-yl)-N-({[2,4-dichlo...)
Show SMILES COc1nc2c(OCc3c(Cl)ccc(N(C)C(=O)CNC(=O)\C=C\c4ccc(NC(C)=O)nc4)c3Cl)cccc2n1C
Show InChI InChI=1S/C29H28Cl2N6O5/c1-17(38)34-24-12-8-18(14-32-24)9-13-25(39)33-15-26(40)36(2)21-11-10-20(30)19(27(21)31)16-42-23-7-5-6-22-28(23)35-29(41-4)37(22)3/h5-14H,15-16H2,1-4H3,(H,33,39)(H,32,34,38)/b13-9+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 0.650n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Concentration required to inhibit specific binding of [3H]-BK(0.06 nM) to the bradykinin receptor B2


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146892
PNG
((E)-3-(6-Acetylamino-pyridin-3-yl)-N-({[2,4-dichlo...)
Show SMILES COc1nc2c(OCc3c(Cl)ccc(N(C)C(=O)CNC(=O)\C=C\c4ccc(NC(C)=O)nc4)c3Cl)cccc2n1Cc1ccccn1
Show InChI InChI=1S/C34H31Cl2N7O5/c1-21(44)40-29-14-10-22(17-38-29)11-15-30(45)39-18-31(46)42(2)26-13-12-25(35)24(32(26)36)20-48-28-9-6-8-27-33(28)41-34(47-3)43(27)19-23-7-4-5-16-37-23/h4-17H,18-20H2,1-3H3,(H,39,45)(H,38,40,44)/b15-11+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 0.680n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Inhibition of [3H]BK (1.0 nM) binding to the human bradykinin receptor B2, expressed in CHO cells


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146906
PNG
(4-((E)-2-{[({2,4-Dichloro-3-[2-methyl-4-(pyridin-2...)
Show SMILES CNC(=O)c1ccc(\C=C\C(=O)NCC(=O)N(C)c2ccc(Cl)c(COc3cccc4c(OCc5ccccn5)cc(C)nc34)c2Cl)cc1OC
Show InChI InChI=1S/C38H35Cl2N5O6/c1-23-18-33(50-21-25-8-5-6-17-42-25)26-9-7-10-31(37(26)44-23)51-22-28-29(39)14-15-30(36(28)40)45(3)35(47)20-43-34(46)16-12-24-11-13-27(38(48)41-2)32(19-24)49-4/h5-19H,20-22H2,1-4H3,(H,41,48)(H,43,46)/b16-12+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 0.690n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Inhibition of [3H]BK (1.0 nM) binding to the human bradykinin receptor B2, expressed in CHO cells


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146911
PNG
((E)-N-[({2,4-Dichloro-3-[2-methyl-4-(pyridin-2-ylm...)
Show SMILES CN(C(=O)CNC(=O)\C=C\c1ccc(cc1)N1CCCC1=O)c1ccc(Cl)c(COc2cccc3c(OCc4ccccn4)cc(C)nc23)c1Cl
Show InChI InChI=1S/C39H35Cl2N5O5/c1-25-21-34(50-23-27-7-3-4-19-42-27)29-8-5-9-33(39(29)44-25)51-24-30-31(40)16-17-32(38(30)41)45(2)37(49)22-43-35(47)18-13-26-11-14-28(15-12-26)46-20-6-10-36(46)48/h3-5,7-9,11-19,21H,6,10,20,22-24H2,1-2H3,(H,43,47)/b18-13+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 0.830n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Inhibition of [3H]BK (1.0 nM) binding to the human bradykinin receptor B2, expressed in CHO cells


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146897
PNG
(CHEMBL98292 | {4-[3-({2-[(E)-3-(6-Acetylamino-pyri...)
Show SMILES CCOC(=O)Cn1c(OC)nc2c(OCc3c(Cl)ccc(N(C)C(=O)CNC(=O)\C=C\c4ccc(NC(C)=O)nc4)c3Cl)cccc12
Show InChI InChI=1S/C32H32Cl2N6O7/c1-5-46-29(44)17-40-24-7-6-8-25(31(24)38-32(40)45-4)47-18-21-22(33)11-12-23(30(21)34)39(3)28(43)16-36-27(42)14-10-20-9-13-26(35-15-20)37-19(2)41/h6-15H,5,16-18H2,1-4H3,(H,36,42)(H,35,37,41)/b14-10+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 0.910n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Inhibition of [3H]BK (1.0 nM) binding to the human bradykinin receptor B2, expressed in CHO cells


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50067281
PNG
(4-{(E)-2-[({[2,4-Dichloro-3-(2-methyl-quinolin-8-y...)
Show SMILES CNC(=O)c1ccc(\C=C\C(=O)NCC(=O)N(C)c2ccc(Cl)c(COc3cccc4ccc(C)nc34)c2Cl)cc1
Show InChI InChI=1S/C31H28Cl2N4O4/c1-19-7-11-21-5-4-6-26(30(21)36-19)41-18-23-24(32)14-15-25(29(23)33)37(3)28(39)17-35-27(38)16-10-20-8-12-22(13-9-20)31(40)34-2/h4-16H,17-18H2,1-3H3,(H,34,40)(H,35,38)/b16-10+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 1.10n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Inhibition of [3H]BK (1.0 nM) binding to the human bradykinin receptor B2, expressed in CHO cells


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146902
PNG
((E)-3-(6-Acetylamino-pyridin-3-yl)-N-[({2,4-dichlo...)
Show SMILES CN(C(=O)CNC(=O)\C=C\c1ccc(NC(C)=O)nc1)c1ccc(Cl)c(COc2cccc3c(OCc4ccccn4)cc(C)nc23)c1Cl
Show InChI InChI=1S/C36H32Cl2N6O5/c1-22-17-31(48-20-25-7-4-5-16-39-25)26-8-6-9-30(36(26)42-22)49-21-27-28(37)12-13-29(35(27)38)44(3)34(47)19-41-33(46)15-11-24-10-14-32(40-18-24)43-23(2)45/h4-18H,19-21H2,1-3H3,(H,41,46)(H,40,43,45)/b15-11+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 1.20n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Concentration required to inhibit specific binding of [3H]-BK(0.06 nM) to the bradykinin receptor B2


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146902
PNG
((E)-3-(6-Acetylamino-pyridin-3-yl)-N-[({2,4-dichlo...)
Show SMILES CN(C(=O)CNC(=O)\C=C\c1ccc(NC(C)=O)nc1)c1ccc(Cl)c(COc2cccc3c(OCc4ccccn4)cc(C)nc23)c1Cl
Show InChI InChI=1S/C36H32Cl2N6O5/c1-22-17-31(48-20-25-7-4-5-16-39-25)26-8-6-9-30(36(26)42-22)49-21-27-28(37)12-13-29(35(27)38)44(3)34(47)19-41-33(46)15-11-24-10-14-32(40-18-24)43-23(2)45/h4-18H,19-21H2,1-3H3,(H,41,46)(H,40,43,45)/b15-11+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 1.20n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Inhibition of [3H]BK (1.0 nM) binding to the human bradykinin receptor B2, expressed in CHO cells


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146894
PNG
(4-{(E)-2-[({[2,4-Dichloro-3-(2-methyl-4-propoxy-qu...)
Show SMILES CCCOc1cc(C)nc2c(OCc3c(Cl)ccc(N(C)C(=O)CNC(=O)\C=C\c4ccc(cc4)C(=O)NC)c3Cl)cccc12
Show InChI InChI=1S/C34H34Cl2N4O5/c1-5-17-44-29-18-21(2)39-33-24(29)7-6-8-28(33)45-20-25-26(35)14-15-27(32(25)36)40(4)31(42)19-38-30(41)16-11-22-9-12-23(13-10-22)34(43)37-3/h6-16,18H,5,17,19-20H2,1-4H3,(H,37,43)(H,38,41)/b16-11+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 1.20n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Concentration required to inhibit specific binding of [3H]-BK(0.06 nM) to the bradykinin receptor B2


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146908
PNG
(4-{(E)-2-[({[2,4-Dichloro-3-(4-isopropoxy-2-methyl...)
Show SMILES CNC(=O)c1ccc(\C=C\C(=O)NCC(=O)N(C)c2ccc(Cl)c(COc3cccc4c(OC(C)C)cc(C)nc34)c2Cl)cc1
Show InChI InChI=1S/C34H34Cl2N4O5/c1-20(2)45-29-17-21(3)39-33-24(29)7-6-8-28(33)44-19-25-26(35)14-15-27(32(25)36)40(5)31(42)18-38-30(41)16-11-22-9-12-23(13-10-22)34(43)37-4/h6-17,20H,18-19H2,1-5H3,(H,37,43)(H,38,41)/b16-11+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 1.20n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Concentration required to inhibit specific binding of [3H]-BK(0.06 nM) to the bradykinin receptor B2


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146901
PNG
(4-((E)-2-{[({2,4-Dichloro-3-[2-methyl-4-(pyridin-2...)
Show SMILES CN(C)C(=O)c1ccc(\C=C\C(=O)NCC(=O)N(C)c2ccc(Cl)c(COc3cccc4c(OCc5ccccn5)cc(C)nc34)c2Cl)cc1
Show InChI InChI=1S/C38H35Cl2N5O5/c1-24-20-33(49-22-27-8-5-6-19-41-27)28-9-7-10-32(37(28)43-24)50-23-29-30(39)16-17-31(36(29)40)45(4)35(47)21-42-34(46)18-13-25-11-14-26(15-12-25)38(48)44(2)3/h5-20H,21-23H2,1-4H3,(H,42,46)/b18-13+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 1.40n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Inhibition of [3H]BK (1.0 nM) binding to the human bradykinin receptor B2, expressed in CHO cells


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146891
PNG
(5-((E)-2-{[({2,4-Dichloro-3-[2-methyl-4-(pyridin-2...)
Show SMILES CNC(=O)c1ccc(\C=C\C(=O)NCC(=O)N(C)c2ccc(Cl)c(COc3cccc4c(OCc5ccccn5)cc(C)nc34)c2Cl)cn1
Show InChI InChI=1S/C36H32Cl2N6O5/c1-22-17-31(48-20-24-7-4-5-16-40-24)25-8-6-9-30(35(25)43-22)49-21-26-27(37)12-14-29(34(26)38)44(3)33(46)19-42-32(45)15-11-23-10-13-28(41-18-23)36(47)39-2/h4-18H,19-21H2,1-3H3,(H,39,47)(H,42,45)/b15-11+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 1.40n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Inhibition of [3H]BK (1.0 nM) binding to the human bradykinin receptor B2, expressed in CHO cells


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146899
PNG
(4-((E)-2-{[({2,4-Dichloro-3-[2-methyl-4-(pyridin-2...)
Show SMILES CNC(=O)c1ccc(\C=C\C(=O)NCC(=O)N(C)c2ccc(Cl)c(COc3cccc4c(OCc5ccccn5)cc(C)nc34)c2Cl)cc1
Show InChI InChI=1S/C37H33Cl2N5O5/c1-23-19-32(48-21-26-7-4-5-18-41-26)27-8-6-9-31(36(27)43-23)49-22-28-29(38)15-16-30(35(28)39)44(3)34(46)20-42-33(45)17-12-24-10-13-25(14-11-24)37(47)40-2/h4-19H,20-22H2,1-3H3,(H,40,47)(H,42,45)/b17-12+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 2.30n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Concentration required to inhibit specific binding of [3H]-BK(0.06 nM) to the bradykinin receptor B2


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146910
PNG
((E)-N-[({2,4-Dichloro-3-[2-methyl-4-(pyridin-2-ylm...)
Show SMILES CN(C(=O)CNC(=O)\C=C\c1ccc(NC(=O)Cc2ccncc2)nc1)c1ccc(Cl)c(COc2cccc3c(OCc4ccccn4)cc(C)nc23)c1Cl
Show InChI InChI=1S/C41H35Cl2N7O5/c1-26-20-35(54-24-29-6-3-4-17-45-29)30-7-5-8-34(41(30)48-26)55-25-31-32(42)11-12-33(40(31)43)50(2)39(53)23-47-37(51)14-10-28-9-13-36(46-22-28)49-38(52)21-27-15-18-44-19-16-27/h3-20,22H,21,23-25H2,1-2H3,(H,47,51)(H,46,49,52)/b14-10+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 2.40n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Inhibition of [3H]BK (1.0 nM) binding to the human bradykinin receptor B2, expressed in CHO cells


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146896
PNG
((E)-3-(6-Acetylamino-pyridin-3-yl)-N-({[3-(1-benzy...)
Show SMILES COc1nc2c(OCc3c(Cl)ccc(N(C)C(=O)CNC(=O)\C=C\c4ccc(NC(C)=O)nc4)c3Cl)cccc2n1Cc1ccccc1
Show InChI InChI=1S/C35H32Cl2N6O5/c1-22(44)40-30-16-12-23(18-38-30)13-17-31(45)39-19-32(46)42(2)27-15-14-26(36)25(33(27)37)21-48-29-11-7-10-28-34(29)41-35(47-3)43(28)20-24-8-5-4-6-9-24/h4-18H,19-21H2,1-3H3,(H,39,45)(H,38,40,44)/b17-13+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 2.5n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Inhibition of [3H]BK (1.0 nM) binding to the human bradykinin receptor B2, expressed in CHO cells


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146890
PNG
(CHEMBL540300 | {8-[2,6-Dichloro-3-(methyl-{2-[(E)-...)
Show SMILES CCOC(=O)COc1cc(C)nc2c(OCc3c(Cl)ccc(N(C)C(=O)CNC(=O)\C=C\c4ccc(cc4)C(=O)NC)c3Cl)cccc12
Show InChI InChI=1S/C35H34Cl2N4O7/c1-5-46-32(44)20-48-29-17-21(2)40-34-24(29)7-6-8-28(34)47-19-25-26(36)14-15-27(33(25)37)41(4)31(43)18-39-30(42)16-11-22-9-12-23(13-10-22)35(45)38-3/h6-17H,5,18-20H2,1-4H3,(H,38,45)(H,39,42)/b16-11+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 2.60n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Inhibition of [3H]BK (1.0 nM) binding to the human bradykinin receptor B2, expressed in CHO cells


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146900
PNG
((E)-3-(6-Acetylamino-pyridin-3-yl)-N-[({2,4-dichlo...)
Show SMILES COCCn1c(OC)nc2c(OCc3c(Cl)ccc(N(C)C(=O)CNC(=O)\C=C\c4ccc(NC(C)=O)nc4)c3Cl)cccc12
Show InChI InChI=1S/C31H32Cl2N6O6/c1-19(40)36-26-12-8-20(16-34-26)9-13-27(41)35-17-28(42)38(2)23-11-10-22(32)21(29(23)33)18-45-25-7-5-6-24-30(25)37-31(44-4)39(24)14-15-43-3/h5-13,16H,14-15,17-18H2,1-4H3,(H,35,41)(H,34,36,40)/b13-9+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 3.5n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Inhibition of [3H]BK (1.0 nM) binding to the human bradykinin receptor B2, expressed in CHO cells


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146898
PNG
(4-{(E)-2-[({[2,4-Dichloro-3-(4-dimethylcarbamoylme...)
Show SMILES CNC(=O)c1ccc(\C=C\C(=O)NCC(=O)N(C)c2ccc(Cl)c(COc3cccc4c(OCC(=O)N(C)C)cc(C)nc34)c2Cl)cc1
Show InChI InChI=1S/C35H35Cl2N5O6/c1-21-17-29(48-20-32(45)41(3)4)24-7-6-8-28(34(24)40-21)47-19-25-26(36)14-15-27(33(25)37)42(5)31(44)18-39-30(43)16-11-22-9-12-23(13-10-22)35(46)38-2/h6-17H,18-20H2,1-5H3,(H,38,46)(H,39,43)/b16-11+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 3.70n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Inhibition of [3H]BK (1.0 nM) binding to the human bradykinin receptor B2, expressed in CHO cells


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50067289
PNG
((E)-3-(6-Acetylamino-pyridin-3-yl)-N-({[2,4-dichlo...)
Show SMILES COc1nc2c(OCc3c(Cl)ccc(N(C)C(=O)CNC(=O)\C=C\c4ccc(NC(C)=O)nc4)c3Cl)cccc2n1C
Show InChI InChI=1S/C29H28Cl2N6O5/c1-17(38)34-24-12-8-18(14-32-24)9-13-25(39)33-15-26(40)36(2)21-11-10-20(30)19(27(21)31)16-42-23-7-5-6-22-28(23)35-29(41-4)37(22)3/h5-14H,15-16H2,1-4H3,(H,33,39)(H,32,34,38)/b13-9+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 4.20n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Inhibition of [3H]BK (1.0 nM) binding to the human bradykinin receptor B2, expressed in CHO cells


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146897
PNG
(CHEMBL98292 | {4-[3-({2-[(E)-3-(6-Acetylamino-pyri...)
Show SMILES CCOC(=O)Cn1c(OC)nc2c(OCc3c(Cl)ccc(N(C)C(=O)CNC(=O)\C=C\c4ccc(NC(C)=O)nc4)c3Cl)cccc12
Show InChI InChI=1S/C32H32Cl2N6O7/c1-5-46-29(44)17-40-24-7-6-8-25(31(24)38-32(40)45-4)47-18-21-22(33)11-12-23(30(21)34)39(3)28(43)16-36-27(42)14-10-20-9-13-26(35-15-20)37-19(2)41/h6-15H,5,16-18H2,1-4H3,(H,36,42)(H,35,37,41)/b14-10+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 4.20n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Concentration required to inhibit specific binding of [3H]-BK(0.06 nM) to the bradykinin receptor B2


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146900
PNG
((E)-3-(6-Acetylamino-pyridin-3-yl)-N-[({2,4-dichlo...)
Show SMILES COCCn1c(OC)nc2c(OCc3c(Cl)ccc(N(C)C(=O)CNC(=O)\C=C\c4ccc(NC(C)=O)nc4)c3Cl)cccc12
Show InChI InChI=1S/C31H32Cl2N6O6/c1-19(40)36-26-12-8-20(16-34-26)9-13-27(41)35-17-28(42)38(2)23-11-10-22(32)21(29(23)33)18-45-25-7-5-6-24-30(25)37-31(44-4)39(24)14-15-43-3/h5-13,16H,14-15,17-18H2,1-4H3,(H,35,41)(H,34,36,40)/b13-9+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 4.60n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Concentration required to inhibit specific binding of [3H]-BK(0.06 nM) to the bradykinin receptor B2


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146903
PNG
(CHEMBL98460 | N-[4-((E)-2-{[({2,4-Dichloro-3-[2-me...)
Show SMILES CN(C(=O)CNC(=O)\C=C\c1ccc(NC(=O)c2ccncc2)cc1)c1ccc(Cl)c(COc2cccc3c(OCc4ccccn4)cc(C)nc23)c1Cl
Show InChI InChI=1S/C41H34Cl2N6O5/c1-26-22-36(53-24-30-6-3-4-19-45-30)31-7-5-8-35(40(31)47-26)54-25-32-33(42)14-15-34(39(32)43)49(2)38(51)23-46-37(50)16-11-27-9-12-29(13-10-27)48-41(52)28-17-20-44-21-18-28/h3-22H,23-25H2,1-2H3,(H,46,50)(H,48,52)/b16-11+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 6.10n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Concentration required to inhibit specific binding of [3H]-BK(0.06 nM) to the B2 receptor in guinea pig ileum membrane;


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146892
PNG
((E)-3-(6-Acetylamino-pyridin-3-yl)-N-({[2,4-dichlo...)
Show SMILES COc1nc2c(OCc3c(Cl)ccc(N(C)C(=O)CNC(=O)\C=C\c4ccc(NC(C)=O)nc4)c3Cl)cccc2n1Cc1ccccn1
Show InChI InChI=1S/C34H31Cl2N7O5/c1-21(44)40-29-14-10-22(17-38-29)11-15-30(45)39-18-31(46)42(2)26-13-12-25(35)24(32(26)36)20-48-28-9-6-8-27-33(28)41-34(47-3)43(27)19-23-7-4-5-16-37-23/h4-17H,18-20H2,1-3H3,(H,39,45)(H,38,40,44)/b15-11+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 6.30n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Concentration required to inhibit specific binding of [3H]-BK(0.06 nM) to the bradykinin receptor B2


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146905
PNG
(4-{(E)-2-[({[2,4-Dichloro-3-(4-methoxy-2-methyl-qu...)
Show SMILES CNC(=O)c1ccc(\C=C\C(=O)NCC(=O)N(C)c2ccc(Cl)c(COc3cccc4c(OC)cc(C)nc34)c2Cl)cc1
Show InChI InChI=1S/C32H30Cl2N4O5/c1-19-16-27(42-4)22-6-5-7-26(31(22)37-19)43-18-23-24(33)13-14-25(30(23)34)38(3)29(40)17-36-28(39)15-10-20-8-11-21(12-9-20)32(41)35-2/h5-16H,17-18H2,1-4H3,(H,35,41)(H,36,39)/b15-10+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 8.10n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Inhibition of [3H]BK (1.0 nM) binding to the human bradykinin receptor B2, expressed in CHO cells


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146908
PNG
(4-{(E)-2-[({[2,4-Dichloro-3-(4-isopropoxy-2-methyl...)
Show SMILES CNC(=O)c1ccc(\C=C\C(=O)NCC(=O)N(C)c2ccc(Cl)c(COc3cccc4c(OC(C)C)cc(C)nc34)c2Cl)cc1
Show InChI InChI=1S/C34H34Cl2N4O5/c1-20(2)45-29-17-21(3)39-33-24(29)7-6-8-28(33)44-19-25-26(35)14-15-27(32(25)36)40(5)31(42)18-38-30(41)16-11-22-9-12-23(13-10-22)34(43)37-4/h6-17,20H,18-19H2,1-5H3,(H,37,43)(H,38,41)/b16-11+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 13n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Inhibition of [3H]BK (1.0 nM) binding to the human bradykinin receptor B2, expressed in CHO cells


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146890
PNG
(CHEMBL540300 | {8-[2,6-Dichloro-3-(methyl-{2-[(E)-...)
Show SMILES CCOC(=O)COc1cc(C)nc2c(OCc3c(Cl)ccc(N(C)C(=O)CNC(=O)\C=C\c4ccc(cc4)C(=O)NC)c3Cl)cccc12
Show InChI InChI=1S/C35H34Cl2N4O7/c1-5-46-32(44)20-48-29-17-21(2)40-34-24(29)7-6-8-28(34)47-19-25-26(36)14-15-27(33(25)37)41(4)31(43)18-39-30(42)16-11-22-9-12-23(13-10-22)35(45)38-3/h6-17H,5,18-20H2,1-4H3,(H,38,45)(H,39,42)/b16-11+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 20n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Concentration required to inhibit specific binding of [3H]-BK(0.06 nM) to the bradykinin receptor B2


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146904
PNG
(4-{(E)-2-[({[2,4-Dichloro-3-(4-cyclopentyloxy-2-me...)
Show SMILES CNC(=O)c1ccc(\C=C\C(=O)NCC(=O)N(C)c2ccc(Cl)c(COc3cccc4c(OC5CCCC5)cc(C)nc34)c2Cl)cc1
Show InChI InChI=1S/C36H36Cl2N4O5/c1-22-19-31(47-25-7-4-5-8-25)26-9-6-10-30(35(26)41-22)46-21-27-28(37)16-17-29(34(27)38)42(3)33(44)20-40-32(43)18-13-23-11-14-24(15-12-23)36(45)39-2/h6,9-19,25H,4-5,7-8,20-21H2,1-3H3,(H,39,45)(H,40,43)/b18-13+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 25n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Concentration required to inhibit specific binding of [3H]-BK(0.06 nM) to the bradykinin receptor B2


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146896
PNG
((E)-3-(6-Acetylamino-pyridin-3-yl)-N-({[3-(1-benzy...)
Show SMILES COc1nc2c(OCc3c(Cl)ccc(N(C)C(=O)CNC(=O)\C=C\c4ccc(NC(C)=O)nc4)c3Cl)cccc2n1Cc1ccccc1
Show InChI InChI=1S/C35H32Cl2N6O5/c1-22(44)40-30-16-12-23(18-38-30)13-17-31(45)39-19-32(46)42(2)27-15-14-26(36)25(33(27)37)21-48-29-11-7-10-28-34(29)41-35(47-3)43(28)20-24-8-5-4-6-9-24/h4-18H,19-21H2,1-3H3,(H,39,45)(H,38,40,44)/b17-13+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 26n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Concentration required to inhibit specific binding of [3H]-BK(0.06 nM) to the bradykinin receptor B2


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146898
PNG
(4-{(E)-2-[({[2,4-Dichloro-3-(4-dimethylcarbamoylme...)
Show SMILES CNC(=O)c1ccc(\C=C\C(=O)NCC(=O)N(C)c2ccc(Cl)c(COc3cccc4c(OCC(=O)N(C)C)cc(C)nc34)c2Cl)cc1
Show InChI InChI=1S/C35H35Cl2N5O6/c1-21-17-29(48-20-32(45)41(3)4)24-7-6-8-28(34(24)40-21)47-19-25-26(36)14-15-27(33(25)37)42(5)31(44)18-39-30(43)16-11-22-9-12-23(13-10-22)35(46)38-2/h6-17H,18-20H2,1-5H3,(H,38,46)(H,39,43)/b16-11+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 30n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Concentration required to inhibit specific binding of [3H]-BK(0.06 nM) to the bradykinin receptor B2


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146893
PNG
(4-{(E)-2-[({[2,4-Dichloro-3-(4-ethoxy-2-methyl-qui...)
Show SMILES CCOc1cc(C)nc2c(OCc3c(Cl)ccc(N(C)C(=O)CNC(=O)\C=C\c4ccc(cc4)C(=O)NC)c3Cl)cccc12
Show InChI InChI=1S/C33H32Cl2N4O5/c1-5-43-28-17-20(2)38-32-23(28)7-6-8-27(32)44-19-24-25(34)14-15-26(31(24)35)39(4)30(41)18-37-29(40)16-11-21-9-12-22(13-10-21)33(42)36-3/h6-17H,5,18-19H2,1-4H3,(H,36,42)(H,37,40)/b16-11+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 34n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Inhibition of [3H]BK (1.0 nM) binding to the human bradykinin receptor B2, expressed in CHO cells


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146909
PNG
(CHEMBL99978 | {8-[2,6-Dichloro-3-(methyl-{2-[3-(4-...)
Show SMILES CNC(=O)c1ccc(\C=C\C(=O)NCC(=O)N(C)c2ccc(Cl)c(COc3cccc4c(OCC(O)=O)cc(C)nc34)c2Cl)cc1
Show InChI InChI=1S/C33H30Cl2N4O7/c1-19-15-27(46-18-30(42)43)22-5-4-6-26(32(22)38-19)45-17-23-24(34)12-13-25(31(23)35)39(3)29(41)16-37-28(40)14-9-20-7-10-21(11-8-20)33(44)36-2/h4-15H,16-18H2,1-3H3,(H,36,44)(H,37,40)(H,42,43)/b14-9+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 50n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Concentration required to inhibit specific binding of [3H]-BK(0.06 nM) to the bradykinin receptor B2


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146904
PNG
(4-{(E)-2-[({[2,4-Dichloro-3-(4-cyclopentyloxy-2-me...)
Show SMILES CNC(=O)c1ccc(\C=C\C(=O)NCC(=O)N(C)c2ccc(Cl)c(COc3cccc4c(OC5CCCC5)cc(C)nc34)c2Cl)cc1
Show InChI InChI=1S/C36H36Cl2N4O5/c1-22-19-31(47-25-7-4-5-8-25)26-9-6-10-30(35(26)41-22)46-21-27-28(37)16-17-29(34(27)38)42(3)33(44)20-40-32(43)18-13-23-11-14-24(15-12-23)36(45)39-2/h6,9-19,25H,4-5,7-8,20-21H2,1-3H3,(H,39,45)(H,40,43)/b18-13+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 61n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Inhibition of [3H]BK (1.0 nM) binding to the human bradykinin receptor B2, expressed in CHO cells


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146894
PNG
(4-{(E)-2-[({[2,4-Dichloro-3-(2-methyl-4-propoxy-qu...)
Show SMILES CCCOc1cc(C)nc2c(OCc3c(Cl)ccc(N(C)C(=O)CNC(=O)\C=C\c4ccc(cc4)C(=O)NC)c3Cl)cccc12
Show InChI InChI=1S/C34H34Cl2N4O5/c1-5-17-44-29-18-21(2)39-33-24(29)7-6-8-28(33)45-20-25-26(35)14-15-27(32(25)36)40(4)31(42)19-38-30(41)16-11-22-9-12-23(13-10-22)34(43)37-3/h6-16,18H,5,17,19-20H2,1-4H3,(H,37,43)(H,38,41)/b16-11+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 77n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Inhibition of [3H]BK (1.0 nM) binding to the human bradykinin receptor B2, expressed in CHO cells


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
BDKRB2


(HUMAN)
BDBM50146909
PNG
(CHEMBL99978 | {8-[2,6-Dichloro-3-(methyl-{2-[3-(4-...)
Show SMILES CNC(=O)c1ccc(\C=C\C(=O)NCC(=O)N(C)c2ccc(Cl)c(COc3cccc4c(OCC(O)=O)cc(C)nc34)c2Cl)cc1
Show InChI InChI=1S/C33H30Cl2N4O7/c1-19-15-27(46-18-30(42)43)22-5-4-6-26(32(22)38-19)45-17-23-24(34)12-13-25(31(23)35)39(3)29(41)16-37-28(40)14-9-20-7-10-21(11-8-20)33(44)36-2/h4-15H,16-18H2,1-3H3,(H,36,44)(H,37,40)(H,42,43)/b14-9+
UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a>1.00E+3n/an/an/an/an/an/a



Fujisawa Pharmaceutical Co. Ltd.

Curated by ChEMBL


Assay Description
Inhibition of [3H]BK (1.0 nM) binding to the human bradykinin receptor B2, expressed in CHO cells


J Med Chem 47: 2853-63 (2004)


Article DOI: 10.1021/jm030468n
BindingDB Entry DOI: 10.7270/Q2JM2BCM
More data for this
Ligand-Target Pair
* indicates data uncertainty>20%